These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32840331)

  • 41. 2008 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2008 Mar; 4(2):110-33. PubMed ID: 18631956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The economic burden of schizophrenia in the United States in 2002.
    Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
    J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost of dementia in Switzerland.
    Kraft E; Marti M; Werner S; Sommer H
    Swiss Med Wkly; 2010; 140():w13093. PubMed ID: 22250014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
    Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caregivers' Sense of Coherence: Implications on Direct and Indirect Costs of Dementia Care.
    Turró-Garriga O; Viñas-Díez V; Conde-Sala JL; Calvó-Perxas L; Cullell-Juncà M; Mas-Vall-Llosera G; Flaqué M; Turon-Estrada A; Juvinyà-Canal D; Mioshi E; Garre-Olmo J
    J Alzheimers Dis; 2020; 78(1):117-126. PubMed ID: 32925037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The increasing burden of Alzheimer disease.
    Sadik K; Wilcock G
    Alzheimer Dis Assoc Disord; 2003; 17 Suppl 3():S75-9. PubMed ID: 14512820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life.
    McCormick WC; Hardy J; Kukull WA; Bowen JD; Teri L; Zitzer S; Larson EB
    J Am Geriatr Soc; 2001 Sep; 49(9):1156-60. PubMed ID: 11559373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Pathways to Alzheimer Disease: Costs Incurred in a Medicare Population.
    Gilden DM; Kubisiak JM; Sarsour K; Hunter CA
    Alzheimer Dis Assoc Disord; 2015; 29(4):330-7. PubMed ID: 25635340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer disease: diagnosis, costs, and dimensions of treatment.
    DeKosky ST; Orgogozo JM
    Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S3-7. PubMed ID: 11669507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
    Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
    Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The economic burden of informal care.
    Andersson A; Levin LA; Emtinger BG
    Int J Technol Assess Health Care; 2002; 18(1):46-54. PubMed ID: 11987441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy.
    Cavallo MC; Fattore G
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):184-90. PubMed ID: 9437435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost of Alzheimer's disease and related dementia in managed-medicare.
    Gutterman EM; Markowitz JS; Lewis B; Fillit H
    J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic burden and managed care considerations for the treatment of insomnia.
    Taddei-Allen P
    Am J Manag Care; 2020 Mar; 26(4 Suppl):S91-S96. PubMed ID: 32282179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating the costs of caring for people with Alzheimer disease in California: 2000-2040.
    Fox PJ; Kohatsu N; Max W; Arnsberger P
    J Public Health Policy; 2001; 22(1):88-97. PubMed ID: 11382092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of donepezil therapy on health costs in a Medicare managed care plan.
    Hill JW; Futterman R; Mastey V; Fillit H
    Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.